Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures
Not Applicable
Completed
- Conditions
- Epilepsy
- Registration Number
- JPRN-jRCT1080224671
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 3750
Inclusion Criteria
Epilepsy participants at least 18 years of age with:
1) Partial seizures (with or without secondary generalized seizures)
2) Primary generalized Tonic-clonic seizures
Exclusion Criteria
Participants previously treated with Fycompa
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method